Mostrar el registro sencillo

dc.contributor.authorCalderón González, Ricardoes_ES
dc.contributor.authorTerán Navarro, Héctores_ES
dc.contributor.authorMarimon, José Maríaes_ES
dc.contributor.authorGonzález Rico, Claudiaes_ES
dc.contributor.authorCalvo Montes, Jorgees_ES
dc.contributor.authorFrande Cabanes, Elisabetes_ES
dc.contributor.authorAlkorta Gurrutxaga, Miriames_ES
dc.contributor.authorFariñas Álvarez, María del Carmen es_ES
dc.contributor.authorMartínez Martínez, Luis es_ES
dc.contributor.authorPérez Trallero, Emilioes_ES
dc.contributor.authorÁlvarez Domínguez, Carmen es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2018-02-05T17:21:53Z
dc.date.available2018-02-05T17:21:53Z
dc.date.issued2016-11es_ES
dc.identifier.issn1664-3224es_ES
dc.identifier.urihttp://hdl.handle.net/10902/12997
dc.description.abstractTwo regions of northern Spain, Gipuzkoa, and Cantabria present high annual incidence of listeriosis (1.86 and 1.71 cases per 100,000 inhabitants, respectively). We report that the high annual incidences are a consequence of infection with highly virulent Listeria monocytogenes isolates linked to fatal outcomes in elderly patients with cancer. In addition, listeriosis patients with cancer present low IL-17A/IL-6 ratios and significantly reduced levels of anti-GAPDH1?22 antibodies, identified as two novel biomarkers of poor prognosis. Analysis of these biomarkers may aid in reducing the incidence of listeriosis. Moreover, GAPDH1?22-activated monocyte-derived dendritic cells of listeriosis patients with cancer seem useful tools to prepare clinical vaccines as they produce mainly Th1 cytokines.es_ES
dc.format.extent9 p.es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Research Foundationes_ES
dc.rights© 2016 Calderon-Gonzalez, Teran-Navarro, Marimon, González-Rico, Calvo-Montes, Frande-Cabanes, Alkorta-Gurrutxaga, Fariñas, Martínez-Martínez, Perez-Trallero and Alvarez-Dominguez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). This Document is protected by Copyright and was first published by Frontiers. All rights reserved. It is reproduced with permission.es_ES
dc.sourceFront. Immunol. Nov 2016 7:541es_ES
dc.titleBiomarker tools to Design Clinical Vaccines Determined from a study of annual Listeriosis Incidence in Northern spaines_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3389/fimmu.2016.00541es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo